Generic Provigil hits US market, but Mylan sues over an FDA 180-day exclusivity ruling
This article was originally published in Scrip
Executive Summary
A US legal battle has begun, after Teva Pharmaceutical Industries said that it is now selling a generic version of its narcolepsy drug Provigil (modafinil).